Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06339879 · ClinicalTrials.gov registry record · NA
Health Effects of Grain Foods in Adults
A NA study of High Whole Grain and Low Sugar and Medium Whole Grain and Low Sugar, sponsored by Purdue University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06339879: Recruiting NA study of High Whole Grain and Low Sugar and Medium Whole Grain and Low Sugar, sponsored by Purdue University.
NCT06339879 is a NA study of High Whole Grain and Low Sugar and Medium Whole Grain and Low Sugar that is actively recruiting participants, run by Purdue University. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06339879, a NA study of High Whole Grain and Low Sugar and Medium Whole Grain and Low Sugar, is actively recruiting participants, sponsored by Purdue University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the effects of eating whole grain foods versus refined grain foods with different amounts of added sugar. It is hypothesized that a diet including grain products will have beneficial effects on taste hedonics, appetite, food/energy intake, body weight, blood pressure, acute and chronic glycemia and acute and chronic lipemia compared to customary diets controlling for added sugars, saturated fats and sodium.
Primary Outcome
blood sugar
Conditions Studied
Interventions
- OTHER High Whole Grain, Low Sugar
- OTHER Low Whole Grain, Low Sugar
- OTHER High Whole Grain, High Sugar
- OTHER Low Whole Grain, High Sugar
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06339879 shows while recruiting
NCT06339879 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with High Whole Grain and Low Sugar appearing as the primary indexed condition, and to 4 interventions - of which High Whole Grain, Low Sugar is the first listed.
NCT06339879 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06339879 about?
NCT06339879 is a clinical study titled "Health Effects of Grain Foods in Adults". This study will assess the effects of eating whole grain foods versus refined grain foods with different amounts of added sugar. It is hypothesized that a diet including grain products will have beneficial effects on taste hedonics, appetite, food/energy intake, body weight, blood pressure, acute an...
What is the current status of trial NCT06339879?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-01-18. Estimated completion is 2026-12-31.
What conditions does trial NCT06339879 study?
This clinical trial studies the following conditions: High Whole Grain and Low Sugar, Medium Whole Grain and Low Sugar, Low Whole Grain and Low Sugar, Low Whole Grain and High Sugar.
What interventions are being tested in trial NCT06339879?
The interventions under investigation include: High Whole Grain, Low Sugar (OTHER), Low Whole Grain, Low Sugar (OTHER), High Whole Grain, High Sugar (OTHER), Low Whole Grain, High Sugar (OTHER).
Who is sponsoring clinical trial NCT06339879?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06339879 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06339879's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI